Collectively, these data indicate that crosstalk between integrin αvβ3 and TGFβ signaling modulates tumor cell response to the rigid bone microenvironment and promotes the transition of tumor cells to a bone-destructive phenotype. This evidence concerns the gene TGFB1 and neoplasm.